Superpower peptides available for pre-order. Get first access.
Cosmetic and topical
Skin & aging
Acetyl hexapeptide-8
Also called Argireline, acetyl hexapeptide-3
Acetyl hexapeptide-8, sold as Argireline, is a cosmetic peptide marketed for expression lines. See how it works, what studies show, and its non-drug status.
- Reviewed by
- William Maish, MD MBA MPH, Clinical Product Lead
- Published
- April 18, 2026
- Last updated
- October 5, 2026
Key takeaway
Acetyl hexapeptide-8, sold in skincare as Argireline, is a synthetic peptide modeled on the nerve protein SNAP-25 and marketed as a topical, "Botox-like" way to soften the appearance of expression lines. In lab and small clinical studies it interferes with the SNARE complex that nerves use to trigger muscle contraction, and a 2013 randomized study found it reduced the appearance of peri-orbital wrinkles over four weeks. It is a cosmetic ingredient rather than a drug, so it does not require FDA approval, and its evidence is rated Moderate.
What is acetyl hexapeptide-8?
Acetyl hexapeptide-8 is a synthetic six-amino acid peptide used as a cosmetic ingredient, best known by the trade name Argireline. It is also called acetyl hexapeptide-3, an older name for the same molecule. Its sequence is patterned on the end of SNAP-251, a protein that nerves use to release the signals that make muscles contract.
It is sold in serums and creams marketed for anti-aging, and it is applied topically to the skin.
How does it work?
Acetyl hexapeptide-8 softens the look of expression lines by reducing the small muscle contractions that create them. Nerves trigger those contractions by releasing a chemical signal, and that release depends on a group of proteins called the SNARE complex1, of which SNAP-25 is a part. In laboratory studies, acetyl hexapeptide-8 mimics the end of SNAP-25 and competes with it, which interferes with SNARE complex formation and reduces the release of the signal that tells the muscle to contract. This is the same broad target as Botox, but acetyl hexapeptide-8 is applied topically and is far milder, not an injection that blocks the nerve.
One important limit is delivery. Because it is a relatively large, water-loving peptide, how well it crosses the skin barrier to reach the nerves underneath is debated2, and that penetration question is a major reason its effect is modest.
Is it FDA-approved?
No, and it does not need to be. The FDA does not approve cosmetics3 or most cosmetic ingredients before they go on the market. Cosmetics are regulated and must be safe when used as directed and properly labeled, but there is no pre-market approval step the way there is for drugs, so no anti-aging peptide in a serum is "FDA-approved."
The line that actually matters for an ingredient like this is the difference between a cosmetic and a drug4. A product is a cosmetic when it is intended to improve appearance, but if it claims to change the structure or function of the skin, such as a claim to paralyze muscles, the FDA can regulate it as an unapproved drug. This is why skincare claims are written around the appearance of lines rather than a promised physiological change.
What is it used for?
Acetyl hexapeptide-8 is used almost entirely in topical anti-aging products. It is included to soften the appearance of expression lines and wrinkles, especially forehead lines and the crow's feet around the eyes. It is one of the most common peptide ingredients in over-the-counter skincare.
What does the research show?
The main controlled evidence is a 2013 randomized, placebo-controlled study1 in 60 people, in which a topical argireline product reduced the appearance of peri-orbital wrinkles over four weeks compared with placebo. A 2025 review2 and other small studies report similar modest improvements, while noting that many studies are small or manufacturer-associated and that skin penetration is a genuine question. The research supports a modest cosmetic benefit, not a result like injectable Botox.
What are the side effects?
Topical acetyl hexapeptide-8 is generally well tolerated, and a cosmetic-industry safety review5 assessed it as safe as used in cosmetics. As with any skincare ingredient, some people can still experience:
- Mild redness
- Irritation
- An allergic reaction
For that reason, a patch test before regular use is sensible. Because the peptide is applied to the skin rather than injected, its safety considerations are those of a typical cosmetic ingredient.
Sources: the 2013 randomized controlled trial of argireline (Wang et al., American Journal of Clinical Dermatology, DOI: 10.1007/s40257-013-0009-91, indexed on PubMed); a 2025 review of acetyl hexapeptide-8 in cosmeceuticals; the Cosmetic Ingredient Review safety assessment; and FDA guidance on how cosmetics are regulated. This document is educational and does not constitute medical advice or a treatment claim.